Yang R, Serrano M, Slater J, Leung E, Koeffler H P
Division of Hematology/Oncology, Cedars-Sinai Research Institute, UCLA School of Medicine 90048, USA.
Biochem Biophys Res Commun. 1996 Jan 5;218(1):254-9. doi: 10.1006/bbrc.1996.0045.
The interaction between cyclin-dependent kinase 4 (CDK4) and its inhibitor p16INK4a (p16) was studied by random mutagenesis and yeast two-hybrid system. The gene encoding p16 was mutagenized randomly and the amino acid changes that affect the binding of p16 to CDK4 were identified. Several amino acid residues were shown to be important for the binding and many of these changes occur at residues conserved in all known human p16 family proteins Most of the mutant p16 proteins that failed to bind to CDK4 contained multiple amino acid changes, and these alterations were observed throughout the entire gene with no apparent mutational patterns or hot spots. Some of the mutations that moderately reduced the binding activity severely affected the kinase-inhibitory activity of p16.
通过随机诱变和酵母双杂交系统研究了细胞周期蛋白依赖性激酶4(CDK4)与其抑制剂p16INK4a(p16)之间的相互作用。对编码p16的基因进行随机诱变,并鉴定出影响p16与CDK4结合的氨基酸变化。已证明几个氨基酸残基对于这种结合很重要,并且这些变化中的许多发生在所有已知人类p16家族蛋白中保守的残基处。大多数未能与CDK4结合的突变p16蛋白包含多个氨基酸变化,并且在整个基因中都观察到了这些改变,没有明显的突变模式或热点。一些适度降低结合活性的突变严重影响了p16的激酶抑制活性。